To sum up, after 8 weeks of feeding trial, the inclusion of an extract rich in HT (0.52 g HT/kg feed) into a HFD led to a decrease in plasma FFA levels, a downregulation of the hepatic mRNA levels of markers related to fatty acid uptake and transport, and a decrease in the protein levels of the fatty acid transporter CD36 in the liver, suggesting a protective role of HT in preventing the development of diet-induced steatosis, as supported by the observed tendency to reduce hepatic fat accumulation. The gene discussed is CD36; the disease is steatosis.